Publications

Formulation development of protein biopharmaceuticals has become increasingly challenging due to new modalities and higher desired drug substance concentrations. The constraint in drug substance supply and the need for a holistic set of analytical methods means that only a small selection of excipients can be thoroughly tested in the wet lab. Until now there have been few in-silico tools developed to refine the candidate excipients selected for wet lab testing. To fill this gap we developed the Excipient Prediction Software (ExPreSo), a machine learning algorithm that suggests inactive ingredients based on the properties of the protein drug substance and target product profile. A dataset of over 350 peptide/protein drug formulations with proven long-term stability was created. The dataset was augmented with predictive features including protein structural properties, protein language model embeddings, and drug product characteristics. Supervised machine learning was conducted to create a model that suggests excipients for each drug substance in the dataset. ExPreSo could successfully predict the presence of the nine most prevalent excipients, with validation scores well above a random prediction, and minimal overfitting. A fast variant of ExPreSo using only sequence-based input features showed similar prediction power to slower models that relied on molecular modeling. Interestingly, an ExPreSo variant with only protein-based input features also showed good performance, proving that the algorithm was resilient to the influence of platform formulations in the dataset. To our knowledge, this is the first time that machine learning has been used to suggest biopharmaceutical excipients. Overall, ExPreSo shows great potential to reduce the time, costs, and risks associated with excipient screening during formulation development.

ArchPharm 2023 Aug;356(8):e2300101
ABDEL-TAWAB M. ET AL: An exploratory study on the effect of mechanical stress on particle formation in monoclonal antibody infusions

JHEP Reports. 2023 Feb; 5(2): 100603
SACHERL J. ET AL: Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance

”A Specialist in Bioinformatics based Stabilization of All kinds of Biological Molecules". ISSN 2831-8331

S. Smith,” Liquid formulation bolstered by AI". ISSN 2644-2787

F. Thomas,” Pharmaceutical Technology Europe 33 (4) 2021.
pharmtech.com/view/focusing-on-accelerated-formulation-strategies

Rentschler Biopharma SE/ Leukocare AG: Contract Pharma_54-58 Advertorial 1020
BHONSLE-DEENG L. and PETROPOULOS K.: Advanced Formulation Development by Design in the Context of Holistic Drug Production

Journal of Pharmaceutical Sciences 109 (2020) 818-829
REINAUER E. ET AL: Algorithm-Based Liquid Formulation Development Including a DoE Concept Predicts Long-Term Viral Vector Stability

European Biopharmaceutical Review January 2019, pages 28-36. © Samedan Ltd
ALTRICHTER J. ET AL: Exploring Amino Acid- Based and Stable Spray- Dried Vaccinations

Rentschler Biopharma SE / LEUKOCARE AG/ Informa Pharma Intelligence
"2018 Survey- Formulation in the Drug Product Development Process": 2018 Survey ‘Formulation in the Drug Product Development Process’, based on research from Informa Pharma Intelligence